The SP100 family’s clinical significance hinges on its expression context and cancer-specific mechanisms, while mechanistically, SP100 family proteins regulate cancer via immune modulation, epigenetic alterations, and oncogenic signaling. This evidence concerns the gene SP100 and cancer.